Medicines news

We have upgraded and refreshed the Australian Clinical Trials website. Learn more about the new site.

Selected Pharmaceutical Benefits Scheme (PBS) medicines can now be prescribed for a 60-days for the price of a single prescription. This means many Australians who have a stable, ongoing health condition can now save money on their regular medication.

Under the first stage of the 60-day dispensing policy, eligible Australians living with chronic health conditions will have access to 92 cheaper Pharmaceutical Benefits Scheme (PBS) medicines.

The Australian Government is making hundreds of medicines cheaper by allowing millions of Australians to buy two months’ worth of medicine for the price of a single prescription.

From 1 January 2023, the maximum price of most PBS medicines for non-concessional patients was reduced from $42.50 to $30. Don’t delay buying your PBS Medicines.

A lower Pharmaceutical Benefits Scheme (PBS) general co-payment from 1 January 2023 will help ease cost-of-living pressures for Australians. Here’s what pharmacists need to know to support their customers.

World Antimicrobial Awareness Week runs from 18 to 24 November every year with this year’s theme Preventing Antimicrobial Resistance Together. It’s an international initiative to increase awareness of the growing problem of resistance to antibiotics and other antimicrobial medicines.

The Australian Government announced a record $503 billion investment in our universal health system in the 2021–22 Budget. We’ve updated our Health Funding Facts tool to use the latest figures. Find out more about our key investment areas.

If you've been affected by the floods in New South Wales and Queensland there are a range of services you can access to stay on top of your health needs.

The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).

We are about to open a consultation about a potential National Medicines Traceability Framework (NMTF) for PBS medicines. If you are an industry participant of the medicine supply chain in Australia, you can take part. Find out how you can get involved and make a submission.

Read about World Antimicrobial Awareness Week (WAAW) 2021. The theme for this year is ‘Spread Awareness: Stop Resistance’.

The Australian Commission on Safety and Quality in Health Carewill lead a review and update of the guiding principles for medication management in residential aged care facilities and in the community to support the safe and quality use of medicines.

The Australian Government has listed a range of medicines for treating multiple sclerosis, asthma and diabetes on the Pharmaceutical Benefits Scheme (PBS). The listings will provide valuable support for more than 51,800 Australians living with these conditions, saving them up to $29,000 a year.

The Government has added a life-changing new eczema medicine to the Pharmaceutical Benefits Scheme (PBS). The $270 million in funding to list the medicine will help up to 3,600 Australians over 12 years of age living with severe eczema.

Read about World Antimicrobial Awareness Week (WAAW) 2020. The theme for this year is 'Antimicrobials: handle with care'.

The Australian Government is providing $25 million through the Medical Research Future Fund (MRFF) for research to improve the safe use of medicines and medicines intervention by pharmacists.

Temporary changes to the PBS will mean people affected by the current bushfires can receive subsidised medicines when a doctor’s prescription is not immediately available.

The Government has added a life changing new medicine for Australians living with advanced breast cancer to the PBS.

The Australian Government is investing $3 million to examine the benefits of medicinal cannabis for pain, symptom and side effect management for cancer patients.